NCT01515787
Clinical Trial Information
Trial Number: NCT01515787 (ClinicalTrials.gov)
Disease Type:
- Gastrointestinal Neoplasm - Colorectal Cancer
Trial Title:
A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision (PROSPECT)
Study ID:
N1048
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01515787-D2 | Dataset NCT01515787-D2-Dataset.csv (ae) is one of 2 datasets associated with PubMed ID 37272534. This dataset contains toxicity data presented in the primary manuscript results section and Supplementary Tables 2A and 2B. |
| NCT01515787-D1 | Dataset NCT01515787-D1-Dataset.csv (final) is one of 2 datasets associated with PubMed ID 37272534. This dataset contains demographic and outcomes data presented in the primary manuscript and Supplementary Tables 3A, 3B, and 4 and the Supplementary Figure. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®